Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1

Fang Chen1, Min Sha1, Yanyang Wang1

  • 1Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210029, People's Republic of China.

Diabetologia
|November 14, 2015
PubMed
Abstract

Insights

High glucose harms pancreatic beta cells by increasing Ets-1. This factor suppresses insulin, linking glucotoxicity to type 2 diabetes dysfunction via PDX-1 inhibition.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Diabetes Research

Background:

  • Glucotoxicity, a consequence of hyperglycemia, impairs pancreatic beta cell function.
  • The precise molecular mechanisms underlying glucotoxicity-induced defects in insulin secretion and gene expression remain unclear.

Purpose of the Study:

  • To elucidate the role of the transcription factor v-ets avian erythroblastosis virus E26 oncogene homologue 1 (Ets-1) in pancreatic beta cell glucotoxicity.

Main Methods:

  • Primary islets and Min6 cells were exposed to high glucose to assess Ets-1 expression.
  • Recombinant adenovirus and transgenic mice models were employed to manipulate Ets-1 levels in beta cells.
  • Chromatin immunoprecipitation and quantitative real-time PCR were utilized to measure promoter binding activities.

Main Results:

  • High glucose upregulated Ets-1 and histone acetylation at the Ets-1 promoter, suppressing insulin secretion and biosynthesis.
  • Ets-1 overexpression altered FOXO1 and FOXA2 binding to the PDX-1 promoter, inhibiting PDX-1 expression.
  • PDX-1 overexpression rescued Ets-1-induced defects, while Ets-1 knockdown prevented hyperglycemia-induced beta cell dysfunction.

Conclusions:

  • Ets-1 acts as a crucial link between glucotoxicity and pancreatic beta cell dysfunction in type 2 diabetes.
  • Inhibition of PDX-1 expression by Ets-1 is a key mechanism contributing to beta cell failure under hyperglycemic conditions.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.9K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
3.1K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
8.4K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.4K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K